| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-09-2943 |
| P698 | PubMed publication ID | 20530697 |
| P2093 | author name string | Michael Kahn | |
| Fumi Takahashi-Yanaga | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neoplastic stem cells | Q1638475 |
| P304 | page(s) | 3153-3162 | |
| P577 | publication date | 2010-06-08 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Targeting Wnt signaling: can we safely eradicate cancer stem cells? | |
| P478 | volume | 16 |
| Q26739665 | A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers |
| Q38867217 | A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma |
| Q39392231 | A new validated mathematical model of the Wnt signalling pathway predicts effective combinational therapy by sFRP and Dkk. |
| Q33577624 | A unified model of the hierarchical and stochastic theories of gastric cancer |
| Q47136896 | ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway |
| Q36341597 | Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signalling |
| Q39290765 | Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche? |
| Q37124069 | Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer |
| Q26751344 | Advances in targeted and immunobased therapies for colorectal cancer in the genomic era |
| Q37583804 | Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets |
| Q35863203 | Altering cancer transcriptomes using epigenomic inhibitors |
| Q64226435 | Amine derivatives of furocoumarin induce melanogenesis by activating Akt/GSK-3β/β-catenin signal pathway |
| Q34311859 | An agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and location |
| Q55091102 | Anti-oncogenic activity of Chibby in the development of human nasopharyngeal carcinoma. |
| Q36466583 | Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells |
| Q46014740 | Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence. |
| Q38757074 | Biological and clinical significance of cancer stem cell plasticity |
| Q35131282 | Biphasic role of chondroitin sulfate in cardiac differentiation of embryonic stem cells through inhibition of Wnt/β-catenin signaling |
| Q37839530 | Breast cancer stem cells: treatment resistance and therapeutic opportunities |
| Q37054060 | CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells |
| Q39289235 | CBP/Catenin antagonists: Targeting LSCs' Achilles heel |
| Q35067887 | CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling. |
| Q26799062 | CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer |
| Q38796646 | Can Stopping Nerves, Stop Cancer? |
| Q27022017 | Can nanomedicines kill cancer stem cells? |
| Q35591995 | Can we safely target the WNT pathway? |
| Q39773200 | Cancer Stem Cells and Pediatric Solid Tumors |
| Q46570572 | Cancer Stem Cells in Head and Neck Carcinomas: Identification and Possible Therapeutic Implications. |
| Q27024816 | Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment |
| Q34778345 | Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway. |
| Q38007261 | Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links |
| Q48278683 | Cancer stem cells as targets for immunotherapy |
| Q28081844 | Cancer stem cells in basic science and in translational oncology: can we translate into clinical application? |
| Q27024651 | Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives |
| Q38161332 | Cancer stem cells in head and neck cancer |
| Q37796629 | Cancer stem cells: a new framework for the design of tumor therapies. |
| Q37861207 | Cancer stem cells: the development of new cancer therapeutics. |
| Q28543151 | Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent manner |
| Q59135502 | Celecoxib in breast cancer prevention and therapy |
| Q33688897 | Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. |
| Q49292906 | Cell-type specific potent Wnt signaling blockade by bispecific antibody |
| Q27026428 | Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer |
| Q44421418 | Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection |
| Q39027075 | Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review |
| Q26777882 | Common stemness regulators of embryonic and cancer stem cells |
| Q38850621 | Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets. |
| Q37552660 | Controversies in cancer stem cells: targeting embryonic signaling pathways |
| Q37833922 | Coordinating changes in cell adhesion and phenotype during EMT-like processes in cancer. |
| Q36414274 | Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance |
| Q47697601 | Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer. |
| Q35864226 | Current trends in targeted therapies for glioblastoma multiforme |
| Q48784827 | Daucosterol Inhibits the Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells via Wnt/β-Catenin Signaling. |
| Q35219277 | Denervation suppresses gastric tumorigenesis |
| Q52582285 | Deptor is a novel target of Wnt/β-catenin/c-Myc and contributes to colorectal cancer cell growth. |
| Q34018958 | Dickkopf1 regulates fate decision and drives breast cancer stem cells to differentiation: an experimentally supported mathematical model |
| Q46475690 | Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling |
| Q34537513 | Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4(+) T-cell subsets, including stem cell memory T-cells |
| Q91816312 | Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 α inhibitor BI6015 |
| Q35560868 | Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen. |
| Q38687471 | Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions |
| Q35098085 | Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment |
| Q38887098 | Downregulation of VANGL1 inhibits cellular invasion rather than cell motility in hepatocellular carcinoma cells without stimulation |
| Q37840943 | Drug discovery approaches to target Wnt signaling in cancer stem cells |
| Q38012254 | Drugging Wnt signalling in cancer |
| Q38275614 | E-cadherin's role in development, tissue homeostasis and disease: Insights from mouse models: Tissue-specific inactivation of the adhesion protein E-cadherin in mice reveals its functions in health and disease |
| Q64136480 | EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression |
| Q38664528 | Effects of pulsed electromagnetic fields on postmenopausal osteoporosis |
| Q38978495 | Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways |
| Q59795305 | Endogenous and exogenous galectin-3 promote the adhesion of tumor cells with low expression of MUC1 to HUVECs through upregulation of N-cadherin and CD44 |
| Q37869838 | Eradication of breast cancer cells in patients with distant metastasis: the finishing touches? |
| Q99241353 | Estrogen receptor-β signaling induces cisplatin resistance in bladder cancer |
| Q37417591 | Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications |
| Q37334480 | Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study |
| Q37066536 | Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells |
| Q26849278 | Frizzled7 as an emerging target for cancer therapy |
| Q24313470 | Functional analysis of novel phosphorylation sites of CREB-binding protein using mass spectrometry and mammalian two-hybrid assays |
| Q64064084 | Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line |
| Q55000578 | Functional miRNAs in breast cancer drug resistance. |
| Q36561625 | GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma |
| Q35795934 | Gastric cancer stem cells: evidence, potential markers, and clinical implications |
| Q36737793 | Gastric stem cells and gastric cancer stem cells |
| Q37959323 | Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist? |
| Q28483663 | Gene expression profiling of liver cancer stem cells by RNA-sequencing |
| Q34765296 | Genetic regulation of prostate development |
| Q37815136 | Genetically informed lung cancer medicine |
| Q31112063 | Gpr177 deficiency impairs mammary development and prohibits Wnt-induced tumorigenesis |
| Q38014365 | Gut stem cells in tissue renewal and disease: methods, markers, and myths |
| Q37646541 | HIV-1 persistence in CD4+ T cells with stem cell-like properties |
| Q37936020 | Head and neck cancer stem cells |
| Q36801771 | Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/ β -Catenin Signaling and Apoptosis Induction |
| Q92670011 | Hypothesis: Retinoblastoma protein inactivation mediates effects of histone deacetylase inhibitor-induced Wnt hyperactivation in colorectal cancer cells |
| Q41273119 | ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population |
| Q30384345 | Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling |
| Q36080584 | Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma |
| Q37708736 | Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation |
| Q51608321 | Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles. |
| Q90640291 | Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells |
| Q39208071 | In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma. |
| Q41612992 | Inhibition of FAK kinase activity preferentially targets cancer stem cells |
| Q39003793 | Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer. |
| Q28481465 | Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling pathway |
| Q36919396 | Inhibition of the Wnt palmitoyltransferase porcupine suppresses cell growth and downregulates the Wnt/β-catenin pathway in gastric cancer |
| Q49569420 | Insufficient microwave ablation-induced promotion of distant metastasis is suppressed by β-catenin pathway inhibition in breast cancer |
| Q35553581 | Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies |
| Q35203271 | Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer |
| Q34995814 | Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription |
| Q26829595 | Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshop |
| Q39055537 | Isolation, identification, and characterization of cancer stem cells: A review |
| Q38786359 | Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation. |
| Q41242686 | LHX6, An Independent Prognostic Factor, Inhibits Lung Adenocarcinoma Progression through Transcriptional Silencing of β-catenin |
| Q28555025 | Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells |
| Q39248886 | Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC. |
| Q38622874 | Mechanisms of tumour resistance against chemotherapeutic agents in veterinary oncology |
| Q64081442 | MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway |
| Q35930474 | MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways |
| Q36061114 | Modulation of Wnt/β-catenin signaling pathway by bioactive food components |
| Q46850333 | Molecular Approaches To Target GPCRs in Cancer Therapy. |
| Q26798420 | Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy |
| Q28553543 | Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/β-Catenin Signaling Pathway |
| Q34868613 | Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology |
| Q34795591 | Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review). |
| Q54329310 | NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy. |
| Q38324456 | Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach |
| Q38127721 | Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy |
| Q64951391 | Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks. |
| Q38448721 | Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer. |
| Q47827202 | Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways. |
| Q38825765 | PKM2 promotes stemness of breast cancer cell by through Wnt/β-catenin pathway |
| Q91560799 | Pan-cancer genomic amplifications underlie a WNT hyperactivation phenotype associated with stem cell-like features leading to poor prognosis |
| Q38363276 | Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies |
| Q46164259 | Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells |
| Q34429484 | Phenotypic screening in cancer drug discovery - past, present and future |
| Q38390837 | Pluripotency transcription factors in the pathogenesis of colorectal cancer and implications for prognosis |
| Q35907565 | Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway |
| Q35685058 | Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells |
| Q36747742 | Preferential eradication of acute myelogenous leukemia stem cells by fenretinide |
| Q37227295 | Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis. |
| Q26738491 | Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling |
| Q38632577 | Proteomic Approaches for Biomarker Panels in Cancer |
| Q35807504 | Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase |
| Q58712209 | RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/β-catenin signaling |
| Q37684607 | Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer. |
| Q36972353 | Regulation of protumorigenic pathways by insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis |
| Q37376205 | Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells |
| Q35536672 | Repurposing the antipsychotic trifluoperazine as an antimetastasis agent |
| Q48239444 | Resveratrol Protects SAMP8 Brain Under Metabolic Stress: Focus on Mitochondrial Function and Wnt Pathway |
| Q37679979 | Role of Notch signaling pathway in pancreatic cancer |
| Q91651955 | Role of Wnt/β-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer |
| Q37965633 | Role of canonical Wnt signaling in endometrial carcinogenesis |
| Q35028775 | SIX2 Effects on Wilms Tumor Biology |
| Q42404921 | SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma. |
| Q38224211 | Safely targeting cancer stem cells via selective catenin coactivator antagonism |
| Q50877576 | Sam68 Offers Selectively Aimed Modulation of Transcription in Cancer Stem Cells. |
| Q38287048 | Secreted frizzled-related protein 4 and its implications in cancer and apoptosis. |
| Q89537609 | Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells |
| Q37907906 | Self-renewal related signaling in myeloid leukemia stem cells |
| Q39016331 | Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer |
| Q91695602 | Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties |
| Q26752554 | Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks |
| Q33827178 | Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC. |
| Q38867041 | Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia |
| Q36136205 | Stem cell quiescence |
| Q38061726 | Stem cells and the skin |
| Q34511615 | Stem memory T cells (TSCM)-their role in cancer and HIV immunotherapies |
| Q92067206 | Sulforaphane Modulates Cell Migration and Expression of β-Catenin and Epithelial Mesenchymal Transition Markers in Breast Cancer Cells |
| Q41143523 | Suppression of the Wnt signaling pathway may contribute to the inhibition of proliferation of human hepatocellular carcinoma SMMC-7721 cells by esculetin |
| Q39009114 | Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways |
| Q40895848 | T cell therapies-are T memory stem cells the answer? |
| Q27023930 | T memory stem cells and HIV: a long-term relationship |
| Q38767082 | Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway |
| Q41912339 | Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers. |
| Q33925257 | Targeting Hedgehog--a cancer stem cell pathway |
| Q37763414 | Targeting Notch to target cancer stem cells. |
| Q26774623 | Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment |
| Q37820099 | Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways |
| Q35181108 | Targeting cancer stem cells in solid tumors by vitamin D. |
| Q42182917 | Targeting cancer stem cells: a new therapy to cure cancer patients. |
| Q37975244 | Targeting embryonic signaling pathways in cancer therapy |
| Q90568402 | Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway |
| Q26770039 | Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives |
| Q26775961 | Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy |
| Q37975555 | Targeting the Hedgehog signaling pathway for cancer therapy |
| Q26991723 | Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28 |
| Q26821978 | Targeting the Wnt pathways for therapies |
| Q35196364 | Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer |
| Q34041619 | The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth |
| Q26801375 | The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human Cancer |
| Q38645695 | The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies. |
| Q27316057 | The Integrated Role of Wnt/β-Catenin, N-Glycosylation, and E-Cadherin-Mediated Adhesion in Network Dynamics |
| Q92081475 | The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy |
| Q49804881 | The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor |
| Q39432100 | The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis |
| Q38699352 | The Wnt signaling pathway in cancer |
| Q34632285 | The Wnt signaling pathway: implications for therapy in osteosarcoma |
| Q38152532 | The Wnt/β-catenin pathway in ovarian cancer: a review. |
| Q30155592 | The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin |
| Q35778321 | The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma |
| Q35214534 | The challenges and the promise of molecular targeted therapy in malignant gliomas |
| Q41092885 | The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum |
| Q28744461 | The difficulty of targeting cancer stem cell niches |
| Q55617784 | The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma. |
| Q24613730 | The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer |
| Q38632898 | The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development |
| Q92457917 | The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway |
| Q38939378 | The soft agar colony formation assay |
| Q38029132 | The ubiquitin-proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer |
| Q38031211 | The utility of hedgehog signaling pathway inhibition for cancer |
| Q92802002 | Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System |
| Q37873514 | Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma |
| Q35505126 | Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin |
| Q84106913 | To differentiate or not--routes towards metastasis |
| Q39264794 | Trending Speculations of Tumor-Initiating Cells in Squamous Cell Cancers of Head and Neck |
| Q38194970 | Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance. |
| Q38617940 | Unconventional MAPK-GSK-3β Pathway Behind Atypical Epithelial-Mesenchymal Transition In Hepatocellular Carcinoma |
| Q92538517 | WNT Signaling in Tumors: The Way to Evade Drugs and Immunity |
| Q38419272 | WNT protein-independent constitutive nuclear localization of beta-catenin protein and its low degradation rate in thalamic neurons |
| Q41613396 | WNT signaling - lung cancer is no exception. |
| Q39088795 | WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production |
| Q35677634 | Water extract of brewers' rice induces apoptosis in human colorectal cancer cells via activation of caspase-3 and caspase-8 and downregulates the Wnt/β-catenin downstream signaling pathway in brewers' rice-treated rats with azoxymethane-induced colo |
| Q95728213 | Wnt Signaling: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma |
| Q36292664 | Wnt addiction of genetically defined cancers reversed by PORCN inhibition |
| Q39594844 | Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation |
| Q34393633 | Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia |
| Q38735754 | Wnt signaling as potential therapeutic target in lung cancer |
| Q38219832 | Wnt signaling in osteosarcoma |
| Q26825936 | Wnt signaling pathway in non-small cell lung cancer |
| Q34543360 | Wnt signaling pathway pharmacogenetics in non-small cell lung cancer |
| Q38874181 | Wnt-C59 arrests stemness and suppresses growth of nasopharyngeal carcinoma in mice by inhibiting the Wnt pathway in the tumor microenvironment. |
| Q38753708 | Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population |
| Q24597197 | Wnt/beta-catenin signaling and small molecule inhibitors |
| Q34959673 | Wnt/catenin signaling in adult stem cell physiology and disease |
| Q35674844 | Wnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy. |
| Q36085806 | Wnt/β-Catenin Signaling in T-Cell Immunity and Cancer Immunotherapy |
| Q36558691 | Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells |
| Q37025924 | Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours |
| Q41077299 | ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC. |
| Q87408050 | [Advances in the molecular mechanisms and prognostic significance of EMT in non-small cell lung cancer] |
| Q36763148 | cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse |
| Q57116044 | is a novel oncogenic prognostic biomarker in human glioblastoma |
| Q42173434 | miR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling |
| Q41967874 | p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells |
| Q35100064 | β-Catenin is required for Ron receptor-induced mammary tumorigenesis |
| Q35058248 | β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells |
Search more.